Pathological cardiac hypertrophy alters intracellular targeting of PDE5 from nitric oxide synthase-3 to natriuretic peptide signaling.

Zhang M, Takimoto E, Lee D, Santos CXC, Nakamura T, Hsu S, Nagayama T, Bedja D, Yuan Y, Eaton P, Shah AM, Kass DA.

Circulation. 2012;126:942-951.